Observational studyBMC women's health2026
Cervical cancer screening practices among patients with autoimmune and inflammatory rheumatic diseases: a descriptive cross-sectional observational study.
Observational study in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05961267 (Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImmunocompromised women with autoimmune and inflammatory rheumatic diseases (AIIRDs) are at increased risk of human papillomavirus (HPV) infection and cervical intraepithelial neoplasia, necessitating appropriate cervical cancer screening (CCS). However, there are still limited reports on CCS practices in patients with AIIRD. We assessed the proportion of women with AIIRDs undergoing CCS in accordance with current European guidelines, and factors associated with appropriate or inappropriate screening.
methodsWe conducted a cross-sectional study at Bordeaux University Hospital (July 2023-July 2024). Women ≥ 18 years with confirmed AIIRDs (systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, Sharp's syndrome, rheumatoid arthritis, or spondyloarthritis) completed a standardized self-administered questionnaire on rheumatologic and gynaecologic follow-up, CCS practices, and knowledge about HPV/CCS.
resultsOf the 309 participants included, 302 provided the date of their last CCS. Of these, 120 were classified as high risk for cervical pathology (receiving targeted therapies or immunosuppressive treatment), and 182 as lower risk. Overall, 188 of 302 women (62.3%) reported undergoing CCS in accordance with current guidelines. However, among high-risk patients, 45 of 120 (37.5%) had received a cervical smear within the past year. Inadequate screening was significantly associated with a low level of education, more frequent rheumatologic follow-up, and limited knowledge of cervical pathology. Notably, 16% of participants reported not knowing the purpose of the cervical smear.
conclusionWomen with AIIRDs may benefit from increased CCS awareness among rheumatologists and improved patient education by gynaecologist to promote screening. Further studies are needed to characterise disease- and treatment-specific risks more accurately, establish appropriate screening intervals, and optimise CCS practices for women with AIIRDs.
trial registrationThe study was registered on ClinicalTrials.gov (NCT05961267, date of registration 2023-07-17).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.